›› KLIFOVET › COMPANY › NEWS


Human Biotech & Animal Health Business Partnering Summit Amsterdam

Presentation on "Regulation Need-to-Knows" by CEO Klaus Hellmann Klifovet AG



The veterinary regulatory road is shorter, and less costly, but still very challenging and difficult. There are many ways in which this regulatory road is less risky than in human health, not least because of the ability to do pilot studies in the client-owned animal population. In fact, almost no pivotal clinical studies fail for lack of effectiveness because pilot studies can be done prior to launching the pivotal study. Klaus Hellmann, a veteran in veterinary health with a wealth of regulatory experience, will discuss how to navigate the registration process in animal health, and share tricks of the trade that you need to know to get your product to market quickly.

visit www.humanbiotechanimalhealthEU.com for more information